This Chinese pharmaceutical company's share more than doubled in Hong Kong on Wednesday following positive news of its trial of a new Covid-19 treatment drug. Michelle Martin has the name.
Your Money with Michelle Martin
3,160 clip(s)
Market View: Japan’s inflation data, US tech crackdown on China, Renault, Ferrari, Chinese Yuan, Tungsten, IHH Healthcare, Asia investment opportunities
Market View: Dell, HP, Samsung, CrowdStrike, Standard Chartered, Vitasoy, Yeo Hiap Seng, Sanofi
Market View: US Fed meeting minutes, Trump’s first-term playbook, Starbucks, Amgen, HP, Sony, Super Hi, Chinese investors cash out